Investor insights
Sectors invested in
Funding rounds participated in
$25M sweet spot round size
Most of their 35 investments are in rounds between $13M and $44M
Investor type
Basic info
Industry
Sectors
Date founded
2018
Investments made
Ascend Gene & Cell Therapies raised $66M on May 9, 2023
Investors: Digitalis Ventures, Abingworth, Ajinomoto Sales (Thailand) Co., Ltd, Cathay Health, - and DCVC Bio
- raised $25M on February 15, 2023
Investors: Novo Holdings, ACCELR8 and DCVC Bio
Verdant Robotics raised $47M on November 29, 2022
Investors: SeaX Ventures, Cavallo Ventures, Future Ventures, AgFunder, Water Lemon Ventures, Cleveland Avenue, Autotech Ventures and DCVC Bio
Novome Biotechnologies raised $44M on September 13, 2022
Investors: 5AM Ventures, Alta Partners, Tencent, Touchdown Ventures, University of Minnesota, Navian Capital and DCVC Bio
Auron Therapeutics raised $48M on July 20, 2022
Investors: Qiming Venture Partners USA, Apollo Ventures, Casdin Capital, LLC, Polaris Partners and DCVC Bio
Sabanto raised $17M on July 1, 2022
Investors: Trimble Ventures, Fulcrum Global Capital, Yara Growth Ventures and DCVC Bio
Unlearn.AI raised $50M on April 19, 2022
Investors: Radical Ventures, 8VC, Data Collective, Insight Partners and DCVC Bio
Creyon Bio raised $40M on March 8, 2022
Investors: Casdin Capital, LLC, Lux Capital and DCVC Bio
Totus Medicines raised $40M on December 9, 2021
Investors: Northpond Ventures, Camford Capital and DCVC Bio
CH4Global raised $13M on October 6, 2021
Investors: Data Collective and DCVC Bio